PAREQ

PAREQ identify predictive biomarkers through analyzing the systematics of a disease.

PAREQ aims to advance personalized medicine by utilizing their novel, Artificial Intelligence–based platform (PAREQ, powered by Qlaym). Working with their partners, they identify predictive markers to streamline the development, positioning and lifetime management of new drugs. Their hallmark discovery, the Cancer States, both alone and in conjunction with additional markers, represents a breakthrough predictive marker that links drug efficacy to commercially-accessible, high-throughput, measurable predictors that can identify or enrich the critical responder populations.